The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...

For allergic rhinitis, nasal steroids are the most effective OTC agents, while the topical spray antihistamine azelastine ...

Nasal Spray Innovation Offers Hope for Traumatic Brain Injury TreatmentA new study led by researchers at Mass General Brigham suggests a nasal ...

People who take prohibited psychedelics like psilocybin or LSD and go to the emergency department for care show a higher risk ...

Three of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, and one of RSU grants vests ratably in equal installments on the second, ...

The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

Compass Pathways gains Stifel's Buy rating as its COMP360 psilocybin treatment advances in Phase 3 trials. Key depression ...